CoreWeave is locked in a severe, sustained downtrend, with the stock down 56.69% over the past year and 47.46% over six months, dramatically underperforming the S&P 500's +15.53% and +7.48% respective gains. At a current price of $61.39, the stock sits just 3.2% above its 52-week low of $59.51 and roughly 56.7% below its 52-week high of $141.79 — effectively trading at the very bottom of its 52-week range (about 3% of the range from the low). This positioning signals capitulation-style selling rather than a healthy pullback; a stock pinned near its lows with a -57.49% max drawdown is exhibiting 'falling knife' characteristics where momentum, not valuation, is driving price. The trend structure offers no evidence of a durable base, and the burden of proof rests on the bulls to demonstrate support formation.

Short-term momentum is decisively negative and accelerating to the downside: the stock fell 26.35% in the past month and 16.15% over three months, with the 1-month decline far outpacing the 3-month decline — a hallmark of trend acceleration rather than deceleration. This is confirmed by the most recent session, in which the stock dropped 11.91% in a single day (from $69.69 to $61.39) on enormous volume of roughly 95 million shares, indicating institutional distribution and forced selling rather than orderly profit-taking. Relative strength metrics are uniformly dismal — -27.57% versus SPY over one month and -72.22% over one year — showing the stock is losing ground to the market at an accelerating rate. The 1-month weakness is consistent with, not divergent from, the 1-year downtrend, which argues against a mean-reversion bounce thesis and instead points to a persistent de-rating tied to fundamental credit concerns.

Key technical levels are stark: immediate support sits at the 52-week low of $59.51, and a decisive breakdown below that level would open the door to fresh price discovery to the downside with no historical floor, likely triggering further momentum-driven liquidation. Resistance is layered far overhead, with the 52-week high of $141.79 representing a 131% advance required just to retest prior highs; intermediate resistance would form around recent breakdown levels near $70–$80. With a short ratio of 2.08 (roughly two days of average volume to cover shorts), short interest is meaningful but not extreme, leaving room for squeezes on any positive catalyst — though the elevated volume on down days suggests sellers currently hold the upper hand. Beta is not provided in the dataset, but the -57.49% max drawdown and 11.9% single-day move imply volatility far in excess of the broader market, warranting materially smaller position sizing and wider stop-losses for any risk-tolerant participant.

Revenue growth remains the strongest part of the CoreWeave story, but the trajectory is showing signs of deceleration at the margin: Q2 2026 revenue reached $2.575 billion, up 112.32% year-over-year from $1.213 billion in Q2 2025, continuing a rapid ascent from $2.078 billion in Q1 2026, $1.572 billion in Q4 2025, and $1.365 billion in Q3 2025. Sequentially, revenue grew roughly 23.9% quarter-over-quarter, which is impressive in absolute terms but represents a slowdown from the explosive early-stage ramp, and the YoY growth rate of 112% compares against a much smaller base a year ago. The revenue base is now annualizing above $10 billion, meaning the law of large numbers will increasingly pressure growth rates, and the absence of segment disclosure limits visibility into customer concentration — a critical risk given the company's reliance on a handful of large AI lab contracts. The investment case now hinges less on whether demand exists (it clearly does) and more on whether that demand can be monetized profitably before financing costs overwhelm the economics.

Profitability remains deeply negative and, importantly, is deteriorating rather than improving: Q2 2026 net income was -$626 million on $2.575 billion of revenue, a net margin of -24.31%, worse than Q1 2026's -$740 million (-35.61% margin) in dollar terms but with margin pressure persistent across quarters. Gross margin has been compressing steadily — from 74.22% in Q2 2025 to 65.86% in Q2 2026 — a roughly 836 basis point erosion that signals rising depreciation, power, and hardware costs as the GPU fleet scales, and the current 71.68% gross margin figure in the valuation data sits above the most recent quarterly print, suggesting further compression risk. Operating income was -$49 million (-1.90% operating margin) in Q2 2026, and the critical culprit is interest expense of $640 million in the quarter — up from $267 million a year earlier — which alone consumes roughly 25% of revenue. The company is not on a credible near-term path to GAAP profitability; the gap between EBITDA ($76 million in Q2 2026, a razor-thin 2.95% EBITDA margin versus 48–52% in prior quarters) and net income is dominated by depreciation and interest, exposing the capital-intensity of the model.

Balance sheet and cash flow metrics reveal the central risk in the CoreWeave thesis: a debt-to-equity ratio of 8.94x, a current ratio of just 0.455 (meaning current liabilities are more than double current assets), and trailing twelve-month free cash flow of -$13.65 billion against capital expenditures of $6.42 billion in Q2 2026 alone. Operating cash flow was positive at $679 million in Q2 2026 but was swamped by capex, and the company funded the gap through $10.07 billion of net financing inflows and $997 million of common stock issuance — a clear dependence on external capital markets that is now being tested as credit default swap spreads hit records. ROE of -34.99% and ROA of -0.24% confirm that shareholder capital is being consumed, not compounded, and the cash position of $6.90 billion, while substantial, covers only about one quarter of the current capex run-rate. The FCF yield is deeply negative, and with debt-to-equity near 9x and interest coverage effectively negative, the company's financial risk profile is among the most leveraged in large-cap technology — making access to credit the single most important variable for the equity.